Rnjak D, Ravlić S, Šola AM, Halassy B, Šemnički J, Šuperba M, Hećimović A, Kurolt IC, Kurtović T, Mačak Šafranko Ž, Polančec D, Bendelja K, Mušlin T, Jukić I, Vuk T, Zenić L, Artuković M.
COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?
Transfusion Clinique et Biologique 2021;28:264;  
POVEZNICA

Primorac D, Stojanović Stipić S, Strbad M, Girandon L, Barlič A, Frankić M, Ivić I, Marasović Krstulović D, Jukić I, Halassy B, Hećimović A, Matišić V, Molnar V.
Compassionate mesenchymal stem cell treatment in a severe COVID-19 patient: a case report
Croatian Medical Journal 2021;62:ap0001;
POVEZNICA

Vuk T, Hećimović A, Jukić I, Ravlić S, Kurtović T, Rnjak D, Halassy B.
COVID-19 convalescent plasma therapy for immunodeficient patients-weighing up risks and benefits.
Transfusion Clinique et Biologique 2021;28:424 (commentary);
POVEZNICA

Pavletić M, Mazor M, Lerga M, Mileta T, Železnjak J, Ružić T, Ravlić S, Palčevski D, Kirinčić J, Mežnarić S, Mišković A, Materljan M, Šustić A, Lisnić B, Juranić Lisnić V.
Fast, Reliable, and Simple Point-of-Care-like Adaptation of RT-qPCR for the Detection of SARS-CoV-2 for Use in Hospital Emergency Departments.
Viruses-Basel 2021;13:2413;
POVEZNICA

Ravlić S, Hećimović A, Kurtović T, Ivančić Jelečki J, Forčić D, Slović A, Kurolt ICh, Mačak Šafranko Ž, Mušlin T, Rnjak D, Jakšić O, Sorić E, Džepina G, Đaković Rode O, Kujavec Šljivac K, Vuk T, Jukić I, Markotić A, Halassy B. Is better standardization of therapeutic antibody quality in emerging diseases epidemics possible?
Frontiers in Immunology 2022;13:816159;
POVEZNICA

Štimac A, Kurtović T, Pavlović N, Halassy B.
Development of improved high-performance liquid chromatography method for the determination of residual caprylic acid in formulations of human immunoglobulins.
Molecules 2022;27:1665;
POVEZNICA

Kurtović T, Ravlić S, Štimac A, Mateljak Lukačević S, Hećimović A, Kazazić S, Halassy B.
Efficient and sustainable platform for preparation of a high-quality immunoglobulin G as an urgent treatment option during emerging virus outbreaks.
Frontiers in Immunology 2022;13:889736;
POVEZNICA

Cokarić Brdovčak M, Materljan J, Šustić M, Ravlić S, Ružić T, Lisnić B, Miklić K, Brizić I, Pribanić Matešić M, Juranić Lisnić V, Halassy B, Rončević D, Knežević Z, Štefan L, Bertoglio F, Schubert M, Čičin-Šain L, Markotić A, Jonjić S, Krmpotić A.
ChAdOx1-S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination.
European Journal of Immunology 2022;52:936-945;
POVEZNICA